-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Biopharma says K1.1 mRNA shows tumor suppression in liver cancer mouse models

PUBT·08/26/2026 13:01:47
Listen to the news
Sunshine Biopharma says K1.1 mRNA shows tumor suppression in liver cancer mouse models
  • Sunshine Biopharma reported in vivo tumor suppression from its K1.1 mRNA lipid nanoparticle program in orthotopic hepatocellular carcinoma mouse models.
  • Systemic delivery restored tumor-suppressor expression in grafted liver tumors in a dose-dependent manner; treatment was described as well tolerated.
  • In vitro results showed antiproliferative activity in several non-small cell lung cancer cell lines.
  • Next phase targets NSCLC with concurrent K1.1 mRNA delivery alongside a cancer vaccine, aiming to convert “cold” tumors into “hot” tumors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608260900ACCESSWRNAPR_____1212274) on August 26, 2026, and is solely responsible for the information contained therein.